806
Views
36
CrossRef citations to date
0
Altmetric
Functional disorder

Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test

, , , , &
Pages 936-943 | Received 12 Feb 2013, Accepted 27 May 2013, Published online: 08 Jul 2013

References

  • Jones R, Lydeard S. Irritable syndrome in the general population. BMJ 1992;304:87–90.
  • Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1983;1:632–4.
  • Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391–5.
  • Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45:II43–7.
  • Kantor LS. A dietary assessment of the US food supply. Washington, DC: Agricultural Economic Report No. 772. US Department of Agriculture, Economic Research Service; 2005.
  • Andersen DE, Nygren A. Four cases of longstanding diarrhoea and colic pains cured by fructose-free diet- a pathogenetic discussion. Acta Medica Scan 1978;203:87–92.
  • Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology 1983;84:26–9.
  • Rumessen JJ, Gudmand-Høyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988;95:694–700.
  • Jones HF, Butler RN, Brooks DA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 2010;300:G202–6.
  • Born P, Zech J, Stark M, Classen M, Lorenz R. Carbohydrate substitutes: comparative study of intestinal absorption of fructose, sorbitol and xylitol. Med Klin (Munich) 1994;89:575–8.
  • Skoog SM, Bharucha AE. Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol 2004;99:2046–50.
  • Choi YK, Johlin FC Jr, Summers RW, Jackson M, Rao SS. Fructose intolerance: an under-recognized problem. Am J Gastroenterol 2003;98:1348–53.
  • Rumessen JJ, Gudmand-Høyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986;27:1161–8.
  • Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988;48:1424–30.
  • Fernandez-Banares F, Esteve-Pardo M, de Leon R, Humbert P, Cabre E, Llovet JM, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993;88:2044–50.
  • Kyaw MH, JF M. Fructose malabsorption. True condition or a variance from normality. J Clin Gastroenterol 2011;45:16–21.
  • Goldstein R, Braverman D, Stankiewicz H. Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints. Isr Med Assoc J 2000;2:583–7.
  • Johlin FC Jr, Panther M, Kraft N. Dietary fructose intolerance: diet modification can impact self-rated health and symptom control. Nutr Clin Care 2004;7:92–4.
  • Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SS. Fructose Intolerance in IBS and Utility of Fructose-Restricted Diet. J Clin Gastroenterol 2008;42:233–8.
  • Molinder HK, Kjellström L, Nylin HB, Agréus LE. Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool. Health Qual Life Outcomes 2009;7:106.
  • Fernández-Beñares F. Reliability of symptom analysis during carbohydrate hydrogen-breath test. Curr Opin Clin Nutr Metab Care 2012;15:494–8.
  • Lied GA, Lillestøl K, Lind R, Valeur J, Morken MH, Valli K, et al. Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol 2011;46:1169–78.
  • Muller-Lissner S, Koch G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, et al. Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. J Clin Epidemiol 2003;56:310–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.